New Results
SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein
Simone Parn, Kush Savsani, View ORCID ProfileSivanesan Dakshanamurthy
doi: https://doi.org/10.1101/2022.04.05.487186
Simone Parn
1Georgetown University, Washington, D.C
Kush Savsani
2Virginia Commonwealth University, Richmond, VA
Sivanesan Dakshanamurthy
3Clinical & Experimental Therapeutics Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC 20057
Article usage
Posted April 06, 2022.
SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein
Simone Parn, Kush Savsani, Sivanesan Dakshanamurthy
bioRxiv 2022.04.05.487186; doi: https://doi.org/10.1101/2022.04.05.487186
Subject Area
Subject Areas
- Biochemistry (11574)
- Bioengineering (8626)
- Bioinformatics (28876)
- Biophysics (14809)
- Cancer Biology (11945)
- Cell Biology (17175)
- Clinical Trials (138)
- Developmental Biology (9309)
- Ecology (14023)
- Epidemiology (2067)
- Evolutionary Biology (18130)
- Genetics (12148)
- Genomics (16621)
- Immunology (11712)
- Microbiology (27705)
- Molecular Biology (11402)
- Neuroscience (60109)
- Paleontology (448)
- Pathology (1849)
- Pharmacology and Toxicology (3185)
- Physiology (4878)
- Plant Biology (10279)
- Synthetic Biology (2850)
- Systems Biology (7291)
- Zoology (1619)